Introduction {#s1}
============

Osteoarthritis (OA) is the commonest form of arthritis in the Western world, and is the leading cause of disability in older adults, with the hand being one of the most frequently affected sites.[@R1] In a country the size of the USA, conservative estimates suggest that there are 12.4 million people aged 65 years and over, with OA (33.6%),[@R2] and 2.9 million adults aged 60 years and over with painful, disabling hand OA[@R3] [@R4] which significantly restricts daily activities, such as dressing and bathing, and evidence shows patients and practitioners perceive that there is little that can be done.[@R5] [@R6] The majority of people with hand OA are managed in primary care but often treatments recommended by guidelines, for example, European League Against Rheumatism (EULAR) recommendations, are not offered.[@R7]

Community-based self-management programmes have been proposed generally by national bodies in the USA and Europe as a potential, cost-effective approach for reducing the impact of OA.[@R8] [@R9] While a number of authors have reviewed the effectiveness of self-management programmes for people with OA,[@R7] [@R10] or evaluated hand OA programmes in secondary care,[@R11] [@R12] as yet there is limited evidence for effective management of hand OA in community-dwelling populations.

Here we report the findings from the first large-scale randomised trial to investigate the clinical effectiveness of two self-management programmes for community-dwelling adults aged 50 years and over with hand OA. This multicentre two-by-two factorial randomised controlled trial addresses the following questions: Is joint protection education delivered by an occupational therapist (OT) more effective in reducing hand pain and disability than no joint protection education in people with hand OA? Is instruction in hand exercises delivered by an OT more effective in reducing hand pain and disability than no instruction in hand exercises in people with hand OA?

Methods {#s2}
=======

Design overview {#s2a}
---------------

This was a randomised controlled factorial trial. The main comparisons were between joint protection and no joint protection, and between hand exercises and no hand exercises.

The Self Management in OA of the Hand (SMOotH) trial was conducted from June 2008 through May 2010 at the Arthritis Research UK Primary Care Centre, Keele University, UK. The trial was approved by the North West 7 Research Ethics Committee UK (rec reference: 07/H1008/235) and was monitored by an Independent Trial Steering Committee and Data Monitoring Committee (Trial registration number ISRCTN 33870549). The protocol, including the statistical analysis plan, has been published previously.[@R13]

Setting and participants {#s2b}
------------------------

Participants aged 50 years and over, registered with five general practices in Central Cheshire and North Staffordshire, UK, were mailed a health survey between June 2008 and April 2009. Responders to the health survey were invited for an assessment at a research clinic to check eligibility for the trial if they: (1) gave consent to further contact; (2) reported hand pain in the last 12 months; (3) reported hand pain, aching or stiffness on 'some days', 'most days' or 'all days' in the last month; (4) had an Australian Canadian Hand OA Outcomes Index (AUSCAN) pain score ≥5 or an AUSCAN function score ≥9[@R14] [@R15]; (5) reported that they had not seen an OT or physiotherapist for their hand problem in the last 6 months; (6) had not had a hand operation, injection nor injured their hands badly enough to see a doctor in the previous 6 months and (7) had no other member of their household participating in the trial. These individuals were mailed a study information sheet about the trial, and a letter inviting them to telephone the research centre should they wish to attend the research clinic.

Those attending the research clinic were assessed for trial eligibility by a research nurse and were included in the trial if they: gave informed consent to participate in the trial; met the American College of Rheumatology (ACR) criteria for features of hand OA,[@R16] [@R17] or had unilateral or bilateral thumb base OA; did not have an alternative clinical diagnosis, such as inflammatory arthritis, and were able to attend for the trial interventions at participating OT departments. Details of consenting eligible participants were forwarded to the research centre and participants were randomised via a remote randomisation service to one of four groups (see below).

Randomisation and interventions {#s2c}
-------------------------------

Randomisation was conducted (with an allocation ratio of 1:1:1:1) by administrative staff at the Keele Musculoskeletal Clinical Trials Unit, Arthritis Research UK Primary Care Centre, who had no clinical involvement in the trial. Randomisation was stratified by participants' general practice, and was completed using random permuted blocks of size 4 (the blocks were randomly selected using a computer-generated random number sequence in an ACCESS database). Randomised allocation of the next patient was concealed from administrative and OT staff until the point of randomisation. Researchers who entered and analysed the data were unaware of treatment allocation.

Participants were randomised to one of four 'cells': (1) joint protection; (2) hand exercises; (3) joint protection and hand exercises combined; (4) no joint protection or hand exercises. Participants in this last cell received written advice only and did not receive occupational therapy sessions. Interventions delivered in all four cells are described in [Box 1](#bx1){ref-type="boxed-text"}. Box 1Interventions delivered to participants***Leaflet and advice***All participants were given standardised written information on self-management approaches for hand osteoarthritis (OA) including general information on looking after hand joints, and using analgesia (reproduced with permission from the Arthritis Research UK leaflets 'Looking after your joints when you have arthritis' and 'Osteoarthritis', respectively (<http://www.arthritisresearchuk.org/>), and the National Institute of Health and Care Excellence (NICE) good practice guidelines.[@R18] Participants were advised to continue with any self-management approaches they were currently using, and were given advice to consult their general practitioner if symptoms continued to be troublesome.For 25% of participants this was the sole intervention.***Joint protection, hand exercises***For the remaining 75% of participants, in addition to receiving the leaflet, they received one of three interventions: joint protection, hand exercises, or a combination of the two. The interventions were all delivered over four group sessions (held once a week) by nine occupational therapists (OTs) in two hospital centres. OTs were rotated every 3 months to minimise the potential for bias. The rotation order was determined by the OTs availability to deliver the specific intervention.Groups included up to six participants, and lasted for a maximum of one hour (1.5 h for the combined intervention). Treatment session duration and participant attendances were recorded by the OTs on case report forms (CRFs). Attendance adherence was audited by the study coordinator (SH), and was defined (a priori) to be per protocol if participants attended: session 1, 2, 3 and 4; sessions 1, 2 and 4; sessions 1, 3 and 4; or sessions 1 and 4. Any participant unable to attend week 1 was booked on to the following course.***Joint protection, hand exercises: core components***Both interventions were based on the 'Looking After Your Joints Programme' for rheumatoid arthritis (RA),[@R19] and included the following core components: a general introduction to the programmeeducation about hand OA and its managementmanaging pain during everyday activitieshow to change habitslong-term and short-term goal settingweekly individually negotiated home programmes to practise skills taughtweekly review of individually negotiated home programmesParticipants were provided with workbooks (relevant to joint protection, hand exercises, or a combination of the two) including key points from each meeting, photographs of people with hand OA demonstrating the intervention and weekly activity diaries to complete.***Joint protection principles***In addition to the core components outlined above, this intervention included the following joint protection principles: distributing the weight of what you lift over several joints (eg, spread the load over two hands)avoiding putting strain on the thumb and repetitive thumb movementsavoiding prolonged grips in one positionusing as large a grip as possiblereducing the effort needed to do a task (eg, use labour-saving gadgets; avoid lifting heavy objects, and reduce the weight of what you lift)energy conservation (activity pacing and planning)***Hand exercises***In addition to the core components outlined above, this intervention included the following stretching and strengthening hand and thumb exercises: stretching exerciseswrist flexion and extension, pronation and supinationtendon glidingradial finger walkingmaking an 'O' with the thumb and index fingerthumb extension, abduction and opposition to the base of the 5th finger***Strengthening exercises*** using an elastic band to provide resistance to thumb extension, thumb abduction and finger extensionusing Play-Doh rolling and forming into a ring to provide resistance to thumb and finger extension, squeezing it into a ball, and pinching off pieces between the thumb and index fingersholding a 0.5--0.75 kg weight while doing wrist flexion and extension exercises in pronation then supinationThe aims of the hand exercise programme were to give the participants a clearer understanding of their hand problem, and to develop a hand exercise routine to help them improve grip strength and dexterity. Participants were guided to start with three repetitions of each exercise, gradually building up to 10 repetitions of each exercise daily (or most days), and to perform the exercises within their limit of discomfort. Exercises could be spread over several exercise sessions during the day and performed more than once a day. Participants were also asked to write down how many times they aimed to practise the exercises.***Joint protection and hand exercises combined***The individual interventions as described above were combined in the same number of sessions but with an additional half an hour added to each session.

Twelve OTs attended a two-day training programme before delivering the joint protection education and instruction in hand exercises (see online supplementary text S1). A pilot study tested the intervention protocol prior to the commencement of the main trial.

Outcomes and follow-up {#s2d}
----------------------

Study outcomes were collected at baseline, 3, 6 and 12 months post-randomisation by postal questionnaire, and in a clinical assessment at 6 months. The primary end point for the trial was at 6-month follow-up. The study was designed so that the research nurse conducting the 6-month clinical assessment was blind to treatment allocation. However, if un-blinding did occur this was recorded.

The primary outcome measure combines the pain and function subscales of the AUSCAN[@R14] [@R15] and global assessment of change[@R23] to determine if participants were 'responders' to treatment using the OARSI-OMERACT criteria[@R24] (for further details see footnote to [table 1](#ANNRHEUMDIS2013203938TB1){ref-type="table"}).

###### 

Treatment effectiveness evaluated for the OARSI responder criteria

  Outcome measure                3 months              6 months              12 months                                                                                                                                 
  ------------------------------ --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------- --------- --------- --------- --------- ---------
  n                              130                   127                   127                   130                   130                   127                   127       130       130       127       127       130
  'Responders' (OARSI)†, n (%)   22 (17)               28 (22)               24 (19)               26 (20)               27 (21)               42 (33)               32 (25)   36 (28)   27 (21)   34 (27)   24 (19)   38 (29)
  Adjusted‡ OR(95% CI)           1.35 (0.68 to 2.68)   0.99 (0.50 to 1.95)   2.10 (1.09 to 4.04)   1.14 (0.59 to 2.20)   1.57 (0.83 to 3.00)   1.76 (0.93 to 3.34)                                                     

\*Reference category.

†Participants met the OARSI responder criteria if (a) relative change in AUSCAN pain or function was ≥50% and absolute change was ≥20 or (b) at least two of the following applied: relative change in pain ≥20% and absolute change ≥10, relative change in function ≥20% and absolute change ≥10 or participants reported they were better, much better, or completely recovered on the global assessment of change question. Absolute change (baseline---follow-up score) and relative change (absolute change/baseline score) were calculated after AUSCAN measures were scaled from 1 to 101 to avoid dividing by 0 when calculating relative change.[@R24] Responses in the 'better', 'much better' or 'completely recovered' categories on the global assessment of change question were defined as 'improvement'.

‡Adjusted for age, gender, social class, General Practitioner (GP) practice and length of time with a hand condition and the other main effect of interest.

AUSCAN, Australian Canadian Hand Osteoarthritis Index; HEx, hand exercise; JP, joint protection; OA, Osteoarthritis.

Self-reported secondary outcomes included AUSCAN pain, stiffness and function, global assessment of change in hand problem, average pain severity over the past 3 days (0--10 numerical rating scale), severity rating of participant-nominated main functional problem over the past 3 days (0--10 numerical rating scale), satisfaction with hand function over the past 3 days (0--10 numerical rating scale), health-related quality of life as measured by the SF12v2,[@R25] and the Arthritis Self Efficacy pain subscale.[@R26] Additionally, the following secondary outcomes were measured by a research nurse at baseline and at the 6-month clinical assessment only[@R13]: (1) grip strength (JAMAR); (2) pinch strength (B & L pinch gauge); (3) functional performance using the grip ability test (GAT).[@R27]

Treatment fidelity {#s2e}
------------------

Self-reported performance of hand exercises and use of joint protection and energy conservation were recorded to assess level of adherence to the intervention.[@R13] [@R22]

Sample size {#s2f}
-----------

In this factorial trial, the sample size calculation was based on the comparison of participants receiving hand exercises (*intervention* group) and not receiving hand exercises (*comparator* group), (the calculation would be identical for the comparison of joint protection vs no joint protection, as hand exercises and joint protection were assumed to be independent treatments).[@R28] In participants in the *comparator* group, 50% would receive only a leaflet and advice, and 50% would receive joint protection education. Based on findings from similar populations of older adults with knee osteoarthritis, we estimated that 25% of participants receiving leaflet and advice only would improve using the OARSI-OMERACT responder criteria, and 45% of those receiving joint protection education would improve.[@R24] [@R29] This gave a combined improvement of 35% in participants in the *comparator* group, that is, those not receiving hand exercises, assuming equal allocation of participants between treatment groups.

Published information was not available to define a minimum clinical important difference for the primary outcome measure. Therefore, after a consensus discussion with the OTs delivering the trial interventions, we estimated a worthwhile difference between groups to be 20%. Hence, the estimate of improvement in the *intervention* group which received hand exercises was 55% (ie, between group differences 35%+20%). To detect a difference of 20% or larger between participants receiving and those not receiving hand exercises, with 80% power and α of 5%, a total of 212 participants with data at baseline and at 6 months was required. To allow for a 15% drop-out over the 6-month post-randomisation period, we planned to recruit 252 participants to the trial, that is, 126 per group for each comparison.

Statistical analysis {#s2g}
--------------------

The main effectiveness analysis was completed on an intention to treat (ITT) basis with imputation of missing data (see online supplementary text S2 and S3 for full details of analysis methods). Continuous outcome measures were analysed using analysis of covariance (ANCOVA), and binary outcomes by logistic regression with treatment differences expressed as mean differences or ORs, as appropriate, with associated 95% CIs. Descriptive statistics were used to describe baseline characteristics of participants by randomised treatment arm and by loss to follow-up. Adherence to hand exercises and use of joint protection techniques were analysed by treatment arm at 3, 6 and 12 months.

Sensitivity analyses of the trial results were conducted using (1) complete-case data and (2) per protocol data at 6 months using the primary outcome. Analyses were completed in STATA 12.0.[@R30] No interim analyses were undertaken during the trial or follow-up period.

Role of the funding source {#s2h}
--------------------------

The trial was funded by the Arthritis Research UK ISRCTN 33870549. The funder played no role in the study.

Results {#s3}
=======

Study recruitment and follow-up {#s3a}
-------------------------------

Trial eligibility, recruitment and follow-up are described in [figure 1](#ANNRHEUMDIS2013203938F1){ref-type="fig"}. Overall follow-up rates (including minimum data collection) were: 3 months, 90% (n=232), 6 months, 85% (n=218), 12 months, 85% (n=219). Rates of loss to follow-up were similar for each intervention arm ([figure 1](#ANNRHEUMDIS2013203938F1){ref-type="fig"}) and were not related to baseline participant characteristics (see online supplementary table S1).

###### 

Recruitment flow diagram for the Smooth trial.
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[Table 1](#ANNRHEUMDIS2013203938TB2){ref-type="table"} shows baseline characteristics of trial participants. The mean (SD) age of participants was 66 (9.1) years, 66% were female; the mean (SD) AUSCAN pain and function scores at trial entry were: pain 9.4 (3.6); function 14.8 (7.6). Overall, differences in participant characteristics across treatment arms at baseline were small, however, some between-group differences were observed for gender, marital status, social class, Body Mass Index and the presence of thumb OA.

###### 

Baseline characteristics of randomised participants

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                                                                            Leaflet and advice\   Joint protection\   Hand exercises\     Combined therapy\   All randomised\
                                                                                            (L and A)\            (JP)\               (HEx)\              (JP and HEx)\       n=257
                                                                                            n=65                  n=62                n=65                n=65                
  ----------------------------------------------------------------------------------------- --------------------- ------------------- ------------------- ------------------- -------------------
  Demographic data                                                                                                                                                            

   Mean (SD): Age (years)                                                                   67.2 (9.5)            65.5 (8.6)          64.5 (9.0)          66.0 (9.3)          65.8 (9.1)

   Female                                                                                   40 (62)               43 (69)             41 (63)             46 (71)             170 (66)

   Married                                                                                  44 (69)               43 (71)             36 (55)             42 (65)             165 (65)

   Routine or manual occupation\*†                                                          34 (52)               24 (39)             32 (49)             31 (48)             121 (47)

   Currently working                                                                        20 (31)               18 (29)             20 (31)             18 (28)             76 (30)

   Mean (SD): Age when left school                                                          15 (1.1)              16 (1.4)            16 (1.2)            15 (1.2)            16 (1.2)

   Left school to go to full-time education or university                                   9 (14)                13 (21)             12 (19)             7 (11)              41 (16)

   Gained qualifications through study as an adult                                          25 (40)               36 (60)             36 (55)             29 (45)             126 (50)

  General health and quality of life                                                                                                                                          

   Body Mass Index ≥25.0 kg/m^2^ (overweight/obese)‡                                        39 (63)               41 (71)             48 (75)             41 (65)             169 (68)

   Mean (SD): SF-12: Physical component (0--100)\*                                          39.7 (12.5)           39.0 (10.4)         41.9 (9.5)          39.9 (10.1)         40.1 (10.7)

   Median (IQR): SF-12: Mental component (0--100)\*                                         52.2 (44.0, 58.0)     55.5 (47.7, 60.0)   50.5 (39.9, 57.7)   56.4 (43.0, 60.5)   53.4 (43.3, 59.2)

  Clinical characteristics of hand problem                                                                                                                                    

   Pain in both hands in last 12 months                                                     60 (92)               52 (84)             57 (88)             56 (88)             225 (88)

   Median (IQR): Number of years with hand problem\*                                        5.0 (3.0, 10.0)       4.0 (2.0, 8.0)      5.0 (2.0, 10.0)     5.0 (2.0, 10.0)     5.0 (2.0, 10.0)

   Mean (SD): AUSCAN---pain (0--20)\*                                                       9.5 (4.0)             10.2 (3.5)          8.8 (3.3)           9.4 (3.7)           9.4 (3.6)

   Mean (SD): AUSCAN---stiffness (0--4)\*                                                   1.6 (1.0)             1.5 (1.1)           1.4 (1.0)           1.5 (1.1)           1.5 (1.0)

   Mean (SD): AUSCAN---function (0--36)\*                                                   14.5 (8.0)            15.9 (7.9)          13.8 (7.2)          15.0 (7.3)          14.8 (7.6)

   Mean (SD): AUSCAN---total (0--12)\*                                                      5.2 (2.2)             5.3 (2.4)           4.7 (1.9)           5.0 (2.3)           5.0 (2.2)

   Mean (SD): Arthritis self-efficacy pain subscale (1--10)\*                               4.8 (1.9)             5.3 (1.7)           5.2 (1.8)           5.1 (1.6)           5.1 (1.8)

   Mean (SD): Hand pain severity on average last 3 days (0--10)\*                           4.7 (2.2)             5.2 (2.1)           4.3 (1.8)           4.4 (1.9)           4.6 (2.0)

   Mean (SD): Severity of main functional problem on average in the last 3 days (0--10)\*   4.9 (2.3)             5.6 (2.5)           4.7 (2.4)           5.0 (2.3)           5.0 (2.4)

   Mean (SD): Satisfaction with hand function last 3 days (0--10)\*                         4.6 (2.2)             5.4 (2.5)           4.6 (2.4)           4.4 (2.0)           4.8 (2.3)

   Median (IQR): Grip strength (lbs)\*                                                      35.0 (25.5, 47.5)     31.8 (17.0, 47.5)   31.0 (21.5, 51.0)   33.5 (22.5, 48.5)   33.5 (22.5, 47.5)

   Mean (SD): Pinch strength (lbs)\*                                                        8.8 (3.3)             8.8 (3.8)           9.0 (3.2)           9.0 (3.3)           8.9 (3.4)

   Median (IQR): Grip ability test (seconds)\*                                              32.2 (26.8, 43.6)     30.2 (24.9, 39.7)   32.2 (26.6, 35.8)   32.1 (27.2, 41.5)   32.0 (26.5, 40.4)

   ACR criteria met§                                                                        59 (91)               56 (90)             59 (91)             56 (86)             230 (90)

   Unilateral or bilateral thumb OA¶                                                        50 (77)               52 (84)             49 (75)             59 (91)             210 (82)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Figures are numbers and percentages unless otherwise stated. Median (IQR) given for outcome measures with a skewed distribution. Total AUSCAN score calculated as (pain/5)+stiffness+(function/9).

\*Data based on imputed data.

†Based on the 'lower supervisory/technical', 'Semiroutine' and 'Routine' groups of the UK Standard Occupation Classification (2000) for current or most recent paid employment.

‡Body Mass Index grouping defined according to the WHO.

§ACR criteria based on clinical features only (symptom frequency assessed prior to clinical assessment).

¶The eligibility criteria for thumb base OA were determined via examination of the hand joints for features of pain and/or tenderness on palpation and observation/palpation of deformity. This definition of thumb OA is in keeping with NICE recommendations for diagnosis of OA in UK Primary Care.[@R18]

ACR, American College of Rheumatology; AUSCAN, Australian/Canadian Hand Osteoarthritis Index; JP, joint protection; NICE, National Institute of Health and Care Excellence; OA, osteoarthritis; SF-12, Short Form Health Survey 12 (V.2).

Main trial results {#s3b}
------------------

Interaction terms for the primary outcome (see online supplementary table S2) and all other outcomes were not statistically significant (p≥0.05), therefore, treatment effects were evaluated from the main effects model (ie, joint protection vs no joint protection; hand exercises vs no hand exercises) after adjustment for predefined potential confounders.

[Table 2](#ANNRHEUMDIS2013203938TB1){ref-type="table"} shows the number (%) of participants classified as 'responders' according to the OARSI criteria. At our primary end point (6 months), the proportion of people meeting the OARSI responder criteria was higher for joint protection (vs no joint protection) and hand exercises (vs no hand exercises). These differences reached statistical significance for the joint protection comparison. No statistically significant differences were observed at 3-month and 12-month follow-up for this measure.

Evaluation of the components of the OARSI responder criteria found no significant differences in mean AUSCAN pain or function subscales for either treatment comparison or any follow-up time point ([table 3](#ANNRHEUMDIS2013203938TB3){ref-type="table"}). The percentage of participants reporting global improvement was significantly higher in the groups receiving joint protection compared with no joint protection, and hand exercises versus no hand exercises at 6 months, and also at 3 months and 12 months for the hand exercises comparison only ([table 3](#ANNRHEUMDIS2013203938TB3){ref-type="table"} and see online supplementary table S3).

###### 

Treatment effectiveness for secondary outcome measures by main treatment effects

  Outcome measure                                              3 months                6 months                12 months                                                                                                                                                             
  ------------------------------------------------------------ ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- ------------- ------------- ------------- ------------- ------------- -------------
   n                                                           130                     127                     127                     130                     130                     127                     127           130           130           127           127           130
  Global assessment of change (%)                                                                                                                                                                                                                                                    
   n (%) Improved†                                             39 (30)                 43 (34)                 29 (23)                 53 (41)                 30 (23)                 52 (41)                 28 (22)       55 (42)       34 (26)       46 (36)       28 (22)       51 (39)
   Adjusted OR(95% CI)                                         1.23 (0.67 to 2.25)     2.48 (1.33 to 4.60)     2.71 (1.39 to 5.25)     2.79 (1.44 to 5.40)     1.82 (0.96 to 3.45)     2.22 (1.20 to 4.11)                                                                           
  AUSCAN pain (0--20)                                                                                                                                                                                                                                                                
   Mean (SD)                                                   9.0 (3.5)               9.3 (3.0)               9.5 (3.4)               8.8 (3.1)               9.4 (4.0)               9.0 (3.9)               9.4 (4.0)     9.0 (3.9)     9.4 (3.9)     9.6 (3.8)     9.9 (3.7)     9.1 (3.9)
   Adjusted mean difference (95% CI)                           0.01 (−0.71 to 0.74)    −0.31 (−1.03 to 0.42)   −0.79 (−1.70 to 0.12)   0.06 (−0.85 to 0.97)    −0.09 (−0.99 to 0.81)   −0.35 (−1.27 to 0.56)                                                                         
  AUSCAN stiffness (0--4)                                                                                                                                                                                                                                                            
   Mean (SD)                                                   1.5 (1.0)               1.5 (1.0)               1.6 (1.0)               1.4 (1.0)               1.6 (1.0)               1.4 (1.0)               1.5 (1.0)     1.5 (1.0)     1.6 (1.0)     1.5 (1.0)     1.7 (0.9)     1.5 (1.0)
   Adjusted mean difference (95% CI)                           0.02 (−0.19 to 0.22)    −0.13 (−0.33 to 0.07)   −0.21 (−0.43 to 0.02)   0.11 (−0.11 to 0.33)    −0.05 (−0.27 to 0.17)   −0.14 (−0.36 to 0.08)                                                                         
  AUSCAN function (0--36)                                                                                                                                                                                                                                                            
   Mean (SD)                                                   15.1 (7.7)              15.3 (6.9)              15.9 (7.7)              14.5 (6.8)              14.4 (7.9)              14.9 (7.5)              15.3 (7.7)    14.1 (7.7)    15.1 (7.9)    16.3 (7.5)    16.3 (7.6)    15.1 (7.8)
   Adjusted mean difference (95% CI)                           −0.61 (−1.96 to 0.74)   −0.70 (−2.03 to 0.62)   −0.36 (−1.85 to 1.14)   −0.51 (−2.04 to 1.02)   0.51 (−1.08 to 2.10)    −0.60 (−2.18 to 0.98)                                                                         
  AUSCAN total (0--12)                                                                                                                                                                                                                                                               
   Mean (SD)                                                   5.0 (2.2)               5.0 (1.9)               5.3 (2.1)               4.7 (1.9)               5.1 (2.3)               4.8 (2.3)               5.1 (2.4)     4.9 (2.3)     5.2 (2.2)     5.3 (2.3)     5.5 (2.2)     5.0 (2.3)
   Adjusted mean difference (95% CI)                           −0.06 (−0.45 to 0.33)   −0.25 (−0.64 to 0.14)   −0.43 (−0.91 to 0.06)   0.09 (−0.39 to 0.57)    −0.03 (−0.51 to 0.46)   −0.26 (−0.74 to 0.22)                                                                         
  Arthritis self-efficacy for pain (1--10)                                                                                                                                                                                                                                           
   Mean (SD)                                                   5.5 (1.9)               6.3 (1.8)               5.8 (2.0)               6.0 (1.7)               5.7 (1.9)               6.5 (1.7)               6.0 (1.8)     6.1 (1.8)     5.4 (2.0)     6.0 (1.8)     5.5 (1.9)     5.8 (2.0)
   Adjusted mean difference (95% CI)                           0.66 (0.24 to 1.08)     0.16 (−0.25 to 0.58)    0.74 (0.30 to 1.19)     0.09 (−0.37 to 0.55)    0.54 (0.07 to 1.02)     0.16 (−0.33 to 0.65)                                                                          
  Hand pain severity last 3 days (0--10)                                                                                                                                                                                                                                             
   Mean (SD)                                                   4.4 (2.2)               4.3 (1.9)               4.6 (2.1)               4.1 (2.0)               4.1 (2.2)               4.4 (2.1)               4.1 (2.1)     4.4 (2.2)     4.5 (2.2)     4.6 (2.3)     4.8 (2.2)     4.3 (2.3)
   Adjusted mean difference (95% CI)                           −0.29 (−0.75 to 0.17)   −0.09 (−0.56 to 0.38)   0.06 (−0.46 to 0.58)    0.53 (0.01 to 1.05)     0.03 (−0.53 to 0.59)    −0.28 (−0.84 to 0.27)                                                                         
  Severity of worse problem in the last 3 days (0--10)                                                                                                                                                                                                                               
   Mean (SD)                                                   4.7 (2.3)               4.7 (2.2)               5.0 (2.3)               4.5 (2.2)               4.8 (2.4)               4.7 (2.6)               4.9 (2.5)     4.7 (2.4)     4.9 (2.2)     4.8 (2.4)     5.2 (2.2)     4.5 (2.3)
   Adjusted mean difference (95% CI)                           −0.23 (−0.75 to 0.30)   −0.27 (−0.78 to 0.24)   −0.42 (−1.07 to 0.24)   −0.01 (−0.65 to 0.62)   −0.33 (−0.90 to 0.23)   −0.49 (−1.08 to 0.10)                                                                         
  Satisfaction with hand function in the last 3 days (0--10)                                                                                                                                                                                                                         
   Mean (SD)                                                   4.8 (2.3)               4.4 (2.2)               4.9 (2.3)               4.3 (2.1)               4.5 (2.4)               4.1 (2.4)               4.2 (2.5)     4.4 (2.4)     4.9 (2.2)     4.8 (2.4)     5.2 (2.2)     4.5 (2.3)
   Adjusted mean difference (95% CI)                           −0.45 (−0.98 to 0.08)   −0.43 (−0.96 to 0.11)   −0.57 (−1.15 to 0.01)   0.37 (−0.22 to 0.95)    −0.19 (−0.75 to 0.38)   −0.46 (−1.06 to 0.14)                                                                         
  Grip strength (lbs)                                                                                                                                                                                                                                                                
   Mean (SD)                                                   N/A                     N/A                     N/A                     N/A                     43.2 (22.8)             41.0 (20.8)             41.3 (21.7)   43.0 (22.0)   N/A           N/A           N/A           N/A
   Adjusted mean difference (95% CI)                           N/A                     N/A                     −1.04 (−4.16 to 2.07)   1.17 (−2.13 to 4.46)    N/A                     N/A                                                                                           
  Pinch strength (lbs)                                                                                                                                                                                                                                                               
   Mean (SD)                                                   N/A                     N/A                     N/A                     N/A                     9.2 (3.5)               8.8 (3.6)               8.8 (3.4)     9.2 (3.7)     N/A           N/A           N/A           N/A
   Adjusted mean difference (95% CI)                           N/A                     N/A                     −0.27 (−0.88 to 0.34)   0.33 (−0.29 to 0.95)    N/A                     N/A                                                                                           
  Grip ability test (seconds)                                                                                                                                                                                                                                                        
   Mean (SD)                                                   N/A                     N/A                     N/A                     N/A                     33.9 (19.2)             31.3 (10.8)             34.5 (19.4)   30.8 (10.6)   N/A           N/A           N/A           N/A
   Adjusted mean difference (95% CI)                           N/A                     N/A                     −1.96 (−5.67 to 1.76)   −2.06 (−5.73 to 1.60)   N/A                     N/A                                                                                           
  SF-12: physical component (0--100)                                                                                                                                                                                                                                                 
   Mean (SD)                                                   40.5 (10.6)             40.3 (10.4)             39.9 (11.0)             41.0 (10.0)             41.7 (10.6)             40.0 (10.6)             39.9 (10.8)   41.8 (10.3)   41.4 (10.8)   40.6 (10.5)   39.7 (10.7)   42.3 (10.6)
   Adjusted mean difference (95% CI)                           0.84 (−0.98 to 2.67)    −0.17 (−2.08 to 1.75)   −0.79 (−2.92 to 1.35)   0.65 (−1.46 to 2.77)    0.01 (−2.24 to 2.25)    1.32 (−0.88 to 3.51)                                                                          
  SF-12: mental component (0--100)                                                                                                                                                                                                                                                   
   Mean (SD)                                                   50.2 (11.0)             51.2 (10.1)             51.1 (10.4)             50.3 (10.7)             50.2 (10.1)             51.4 (10.2)             50.8 (10.7)   50.8 (9.8)    50.4 (11.0)   51.5 (10.5)   50.7 (11.2)   51.1 (10.3)
   Adjusted mean difference (95% CI)                           −1.40 (−3.39 to 0.58)   0.34 (−1.64 to 2.32)    −0.72 (−2.97 to 1.53)   0.86 (−1.33 to 3.05)    −0.98 (−3.42 to 1.46)   1.35 (−0.98 to 3.69)                                                                          

Results based on the sample after multiple imputation of missing data has been completed and after adjustment for baseline (except for global assessment of change), age, gender, social class, General Practitioner (GP) practice, length of time with a hand condition and the other main effect of interest. Total AUSCAN score calculated as (pain/5)+stiffness+(function/9).

\*Reference category.

†'Improvement' defined as 'completely better', 'much better', or 'better' on the global assessment of change question.

AUSCAN, Australian Canadian Hand Osteoarthritis Index; HEx, hand exercise; N/A, not applicable; JP, joint protection; SF-12, Short Form Health Survey 12 (V.2).

From the remaining secondary outcomes ([table 3](#ANNRHEUMDIS2013203938TB3){ref-type="table"}), arthritis pain self-efficacy consistently showed statistically significant differences between those receiving, and those not receiving joint protection, at all time points, with participants receiving joint projection showing increased pain self-efficacy.

Treatment fidelity {#s3c}
------------------

Those allocated to hand exercises performed a structured exercise programme more often than those who were not (see online supplementary table S4). On average, participants allocated to joint protection used joint protection and energy conservation techniques more frequently than those who were not (see online supplementary table S4).

Sensitivity analyses {#s3d}
--------------------

Overall, these findings were largely replicated in a complete case analysis with no imputation of missing data (see online supplementary table S5). A per-protocol analysis of the OARSI responder criteria at 6-month follow-up replicated results from the ITT analysis, although statistical significance of the joint protection comparison was marginal (p=0.07) (see online supplementary table S6).

Adverse events {#s3e}
--------------

No adverse events were reported as a result of the interventions.

Discussion {#s4}
==========

In this multicentre randomised controlled factorial trial, we evaluated whether joint protection education delivered by OTs was more effective in reducing hand pain and disability than no joint protection in community-dwelling older adults with hand OA. At 6 months, the primary end point, participants who received the joint protection intervention were statistically significantly more likely to be classified as responders to treatment than those not receiving joint protection (33% cf 21%). This was not maintained over 12 months. We also evaluated whether instruction in hand exercises was more effective in reducing hand pain and disability than no instruction in hand exercises, and found there was no statistically significant difference in the number of 'responders' between those receiving and not receiving hand exercises. Participants receiving joint protection education reported improved pain self-efficacy at 3- , 6- and 12-months.

The research question arose from clinical practice and was shaped by OT and patient and public involvement.[@R13] We followed the OMERACT-OARSI recommendations for design and conduct of clinical trials of OA.[@R16] Our trial, therefore, had good internal validity with adequate sample size, high follow-up rates and strategies to minimise potential therapist effect. However, because we selected volunteers who indicated that they were able and willing to participate in an OT programme, the results may not be generalisable to all older adults with hand OA.

All participants received the same advice and leaflet from the research nurse on entry into the trial prior to randomisation, and there were no differences between groups in the timing of this. Additional intervention was delivered using the same protocol for timing of treatment appointments for each arm (no additional treatment; joint protection; hand exercises; joint protection and hand exercises) and appointments for classes were monitored. Benefit of classes may have been diluted at 3 months as some participants failed to attend the first set of classes available so were still completing classes after the 3-month follow-up.

Reviews of non-surgical treatments for hand OA[@R31] and international guidelines[@R7] [@R8] have identified a gap in evidence for the effectiveness of non-pharmacological approaches in the management of hand OA in community-dwelling older adults. Guidelines acknowledge that the strength of the evidence underpinning recommendations for self-management is weak. They highlight one RCT[@R12] comparing a joint protection programme plus home-based hand exercise (range of motion) versus information alone in 40 patients with hand OA. Stamm\'s study, while small, has been instrumental in informing clinical guidelines for hand OA.[@R7] [@R8] More recently, Stukstette *et al*[@R11] investigated the effectiveness of an intensive group-based multidisciplinary treatment programme incorporating self-management, ergonomic principles and exercises. The findings of this study in participants recruited from rheumatology clinics suggest that such a programme is not effective in the short term.

Our study has added to this evidence by investigating the independent effects of each intervention and demonstrating the effectiveness of joint protection in hand OA. All exercises were supervised in the classes by OTs experienced in treating hand OA, however, as we did not measure biomechanical outcome, we cannot determine whether our exercise programme had any effect (positive or negative) on joint deformities. Adherence to home exercises was good---those allocated to hand exercises performed a structured exercise programme more often than those who were not---but gains in grip strength and other performance measures were not shown to be statistically significant, contrary to findings of others.[@R32] Adherence to joint protection approaches was also good, and it is possible that once joint protection principles are established, they may be easier to sustain in the shorter term, but the benefits tailor off in the longer term.

Although the magnitude of benefit for joint protection was lower than our prespecified minimally clinically important difference, it still reached statistical significance due to the additional power available in our study from an overestimation of the percentage of participants meeting the OARSI responder criteria in the sample size calculation. Our study, therefore, adds to the evidence for expected differences between interventions and comparators for non-pharmacological studies in community-dwelling populations, 50 years and older, with hand OA.

In clinical practice, only those patients who seek help are treated and only a small subgroup of the population with disabling hand pain in community-dwelling populations, aged 50 years and older, see an OT (3% in a 12-month period).[@R6] Our eligible study population was defined using criteria recommended in secondary care settings,[@R16] and the treatment approaches should, therefore, be generalisable to patients who are referred to OT. Our findings also highlight the feasibility of supporting self-management in community settings and offer strategies to close the gap between what patients should receive[@R7] and what therapies are offered.[@R6]

While hand OA is common, and has a significant impact and associated disability,[@R34] consultations with a General Practitioner (GP) are low.[@R6] People with hand problems consider the diagnosis of 'hand OA' to represent a serious condition, but they often perceive that nothing can be done.[@R5] Our study population was recruited via the community using the ACR criteria for hand OA, hence, to have achieved any improvement in this group is important.

Joint pain in older adults and OA are public health problems that challenge our healthcare professionals and healthcare delivery systems. We have produced clear evidence about the most clinically effective methods of delivering and supporting self-management at 6 months for older adults with hand OA to justify and inform guidelines and recommendations. We have shown that support for self-management, through a joint protection education programme delivered by OTs, provides an effective approach for community-dwelling older adults with hand OA.
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